These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2884746)

  • 1. The Chernoff-Kavlock assay: its validation and application in rats.
    Wickramaratne GA
    Teratog Carcinog Mutagen; 1987; 7(1):73-83. PubMed ID: 2884746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The teratogenic potential and dose-response of dermally administered ethylene glycol monomethyl ether (EGME) estimated in rats with the Chernoff-Kavlock assay.
    Wickramaratne GA
    J Appl Toxicol; 1986 Jun; 6(3):165-6. PubMed ID: 3722711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Workshop on the Chernoff/Kavlock preliminary developmental toxicity test.
    Hardin BD; Becker RA; Kavlock RJ; Seidenberg JM; Chernoff N
    Teratog Carcinog Mutagen; 1987; 7(1):119-27. PubMed ID: 2884739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A summary of the results of 55 chemicals screened for developmental toxicity in mice.
    Seidenberg JM; Becker RA
    Teratog Carcinog Mutagen; 1987; 7(1):17-28. PubMed ID: 2884740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the statistical analysis of Chernoff/Kavlock test data.
    Burg JR; Hardin BD
    Teratog Carcinog Mutagen; 1987; 7(1):49-54. PubMed ID: 2884742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Currently used alternatives to the Chernoff-Kavlock short-term in vivo reproductive toxicity assay.
    Christian MS; Hoberman AM; Lochry EA
    Teratog Carcinog Mutagen; 1987; 7(1):65-71. PubMed ID: 2884744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An indirect assessment of the Chernoff/Kavlock assay.
    Palmer AK
    Teratog Carcinog Mutagen; 1987; 7(1):95-106. PubMed ID: 2884748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Chernoff/Kavlock test for developmental toxicity. Proceedings of the Workshop on the Chernoff/Kavlock Short Term In Vivo Developmental Toxicity Test. Cincinnati, Ohio, May 20 and 21, 1986.
    Teratog Carcinog Mutagen; 1987; 7(1):1-127. PubMed ID: 2884736
    [No Abstract]   [Full Text] [Related]  

  • 9. A recommended protocol for the Chernoff/Kavlock preliminary developmental toxicity test and a proposed method for assigning priority scores based on results of that test.
    Hardin BD
    Teratog Carcinog Mutagen; 1987; 7(1):85-94. PubMed ID: 2884747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the preliminary developmental toxicity screen for chemical hazard identification under the Toxic Substances Control Act.
    Francis EZ; Farland WH
    Teratog Carcinog Mutagen; 1987; 7(1):107-17. PubMed ID: 2884738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the use of neonatal birth weight, growth, viability, and survival data for predicting developmental neurotoxicity: a survey of the literature.
    Goldey ES; Tilson HA; Crofton KM
    Neurotoxicol Teratol; 1995; 17(3):313-32. PubMed ID: 7542737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental toxicity screen: results of rat studies with diethylhexyl phthalate and ethylene glycol monomethyl ether.
    Morrissey RE; Harris MW; Schwetz BA
    Teratog Carcinog Mutagen; 1989; 9(2):119-29. PubMed ID: 2568021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental toxicity and structure-activity relationships of aliphatic acids, including dose-response assessment of valproic acid in mice and rats.
    Narotsky MG; Francis EZ; Kavlock RJ
    Fundam Appl Toxicol; 1994 Feb; 22(2):251-65. PubMed ID: 8005377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evaluation of an in vivo teratology screen.
    Kavlock RJ; Short RD; Chernoff N
    Teratog Carcinog Mutagen; 1987; 7(1):7-16. PubMed ID: 2884745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-implantation embryo culture: validation with selected compounds for teratogenicity testing.
    Cicurel L; Schmid BP
    Xenobiotica; 1988 Jun; 18(6):617-24. PubMed ID: 3420940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipterex teratogenicity in the rat, hamster, and mouse when given by gavage.
    Staples RE; Goulding EH
    Environ Health Perspect; 1979 Jun; 30():105-13. PubMed ID: 446441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental toxicity study with triethylene glycol given by gavage to CD rats and CD-1 mice.
    Ballantyne B; Snellings WM
    J Appl Toxicol; 2005; 25(5):418-26. PubMed ID: 16092104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of p-nonylphenol (NP) and diethylstilboestrol (DES) on the Alderley Park (Alpk) rat: comparison of mammary gland and uterus sensitivity following oral gavage or implanted mini-pumps.
    Odum J; Pyrah IT; Soames AR; Foster JR; Van Miller JP; Joiner RL; Ashby J
    J Appl Toxicol; 1999; 19(5):367-78. PubMed ID: 10513683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of developmental toxicity evident at term to postnatal growth and survival using ethylene glycol monoethyl ether, ethylene glycol monobutyl ether and ethanol.
    Wier PJ; Lewis SC; Traul KA
    Teratog Carcinog Mutagen; 1987; 7(1):55-64. PubMed ID: 2884743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogenicity, fetal and placental toxicity of 1,3,5-trioxane administered to pregnant female rats.
    Sitarek K; Barański B; Stetkiewicz J; Stetkiewicz I
    Pol J Occup Med; 1988; 1(1):51-61. PubMed ID: 2980151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.